X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7979) 7979
Book Review (1889) 1889
Publication (538) 538
Newsletter (193) 193
Newspaper Article (81) 81
Magazine Article (50) 50
Book Chapter (42) 42
Conference Proceeding (21) 21
Trade Publication Article (12) 12
Book / eBook (11) 11
Dissertation (9) 9
Reference (2) 2
Transcript (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6439) 6439
humans (5847) 5847
proton pump inhibitors (4567) 4567
male (3362) 3362
female (2957) 2957
middle aged (2288) 2288
gastroenterology & hepatology (2141) 2141
adult (1974) 1974
omeprazole (1826) 1826
pharmacology & pharmacy (1801) 1801
aged (1754) 1754
proton pump inhibitors - therapeutic use (1501) 1501
proton pump inhibitors - administration & dosage (1415) 1415
treatment outcome (1398) 1398
proton pump inhibitor (1240) 1240
animals (1057) 1057
lansoprazole (1056) 1056
risk factors (1047) 1047
helicobacter infections - drug therapy (994) 994
gastroesophageal reflux - drug therapy (982) 982
helicobacter pylori (968) 968
drug therapy, combination (966) 966
proton pump inhibitors - adverse effects (938) 938
gastroesophageal reflux (873) 873
abridged index medicus (812) 812
therapy (790) 790
medicine & public health (772) 772
dosage and administration (768) 768
anti-ulcer agents - administration & dosage (726) 726
care and treatment (725) 725
omeprazole - administration & dosage (716) 716
anti-ulcer agents - therapeutic use (708) 708
2-pyridinylmethylsulfinylbenzimidazoles (700) 700
drug therapy (679) 679
aged, 80 and over (659) 659
drug administration schedule (651) 651
research (633) 633
omeprazole - analogs & derivatives (632) 632
drug interactions (630) 630
medicine, general & internal (628) 628
risk (597) 597
health aspects (586) 586
time factors (568) 568
gastroesophageal-reflux disease (564) 564
rabeprazole (558) 558
pharmacokinetics (548) 548
double-blind (539) 539
dose-response relationship, drug (538) 538
prospective studies (537) 537
adolescent (536) 536
hydrogen-ion concentration (534) 534
omeprazole - therapeutic use (531) 531
proton-pump inhibitors (512) 512
internal medicine (505) 505
retrospective studies (503) 503
pantoprazole (487) 487
young adult (487) 487
management (484) 484
gastroenterology (478) 478
rats (456) 456
infection (455) 455
anti-bacterial agents - administration & dosage (449) 449
analysis (446) 446
esomeprazole (446) 446
anti-bacterial agents - therapeutic use (442) 442
disease (441) 441
helicobacter pylori - drug effects (435) 435
proton pump inhibitors - pharmacology (425) 425
administration, oral (423) 423
complications and side effects (422) 422
gastroesophageal reflux disease (414) 414
oncology (406) 406
metaanalysis (394) 394
gastric acid - secretion (386) 386
omeprazole - pharmacology (385) 385
clopidogrel (378) 378
double-blind method (368) 368
amoxicillin - administration & dosage (363) 363
drugs (363) 363
diagnosis (354) 354
protons (354) 354
2-pyridinylmethylsulfinylbenzimidazoles - administration & dosage (351) 351
endoscopy (351) 351
nonsteroidal antiinflammatory drugs (349) 349
histamine h2 antagonists - therapeutic use (347) 347
prevention (347) 347
aspirin (340) 340
surgery (340) 340
ulcers (340) 340
efficacy (332) 332
ticlopidine - analogs & derivatives (332) 332
eradication (325) 325
helicobacter-pylori infection (324) 324
clarithromycin - administration & dosage (322) 322
pharmacology/toxicology (321) 321
anti-inflammatory agents, non-steroidal - adverse effects (319) 319
follow-up studies (319) 319
prevalence (316) 316
triple therapy (311) 311
peptic ulcer (308) 308
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7763) 7763
Japanese (119) 119
German (118) 118
Russian (88) 88
Spanish (75) 75
French (63) 63
Korean (58) 58
Italian (12) 12
Chinese (11) 11
Hungarian (8) 8
Danish (7) 7
Polish (7) 7
Norwegian (6) 6
Czech (5) 5
Dutch (5) 5
Swedish (5) 5
Ukrainian (4) 4
Portuguese (2) 2
Lithuanian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2010, Volume 56, Issue 2, pp. 134 - 143
Journal Article
世界胃肠病学杂志:英文版(电子版), ISSN 1007-9327, 2014, Volume 20, Issue 45, pp. 17127 - 17131
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2016, Volume 14, Issue 6, pp. 809 - 815.e1
Journal Article
Canadian Medical Association Journal, ISSN 0008-4409, 03/2009, Volume 180, Issue 7, pp. 713 - 718
Journal Article
AURIS NASUS LARYNX, ISSN 0385-8146, 02/2017, Volume 44, Issue 1, pp. 122 - 125
Presently, the relationship between laryngopharyngeal reflux (LPR) and radiation-induced mucositis has not been fully explored. In the present study, we report... 
Laryngopharyngeal reflux | HEAD | Mucositis | OTORHINOLARYNGOLOGY | Radiation | Head and neck cancer | RADIOTHERAPY | NECK-CANCER | Proton pump inhibitor
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 61, Issue 8, pp. 872 - 879
Objectives This study sought to determine whether known genetic, drug, dietary, compliance, and lifestyle factors affecting clopidogrel absorption and... 
Cardiovascular | Internal Medicine | pharmacokinetics | risk factors | receptors | drugs | platelets | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | GENOTYPE | REACTIVITY | TRIAL | CIGARETTE-SMOKING | PARAOXONASE-1 | RESISTANCE | PRASUGREL | ABSORPTION | ASSOCIATION | Area Under Curve | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Male | Drug Monitoring - methods | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - blood | Ticlopidine - administration & dosage | Adult | Female | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Drug Therapy, Combination | Platelet Aggregation - genetics | Cardiovascular Diseases - etiology | 2-Pyridinylmethylsulfinylbenzimidazoles - pharmacokinetics | Platelet Function Tests - methods | Aryldialkylphosphatase - genetics | Ticlopidine - analogs & derivatives | Polymorphism, Genetic | Cross-Over Studies | Smoking - metabolism | Confounding Factors (Epidemiology) | Proton Pump Inhibitors - pharmacokinetics | Blood Coagulation - drug effects | ATP-Binding Cassette, Sub-Family B, Member 1 - genetics | Cytochrome P-450 CYP2C19 | ATP Binding Cassette Transporter, Sub-Family B | Cardiovascular Diseases - psychology | Patient Compliance | 2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage | Phosphates | Drugs | Prescribing | Medical colleges | Continuing medical education | Metabolites | Vasodilators | Cytochrome P-450 | Physiological aspects | Proton pump inhibitors | Genetic aspects | Patient compliance | Research institutes | Studies | Cytochrome | Body mass index | Nutrition research | Genotype & phenotype | Demographics | Drug therapy | Acute coronary syndromes | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Gut, ISSN 0017-5749, 01/2018, Volume 67, Issue 1, pp. 28 - 35
Journal Article
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 01/2011, Volume 89, Issue 1, pp. 65 - 74
Four randomized, placebo‐controlled, crossover studies were conducted among 282 healthy subjects to investigate whether an interaction exists between... 
VARIABILITY | LANSOPRAZOLE | RABEPRAZOLE | THERAPY | CARDIOVASCULAR EVENTS | STENT PLACEMENT | PHARMACOLOGY & PHARMACY | OUTCOMES | ANTIPLATELET ACTION | PROTON-PUMP INHIBITORS | DRUG-INTERACTION | Proton Pump Inhibitors - pharmacology | Ticlopidine - pharmacology | Humans | Middle Aged | Half-Life | Male | 2-Pyridinylmethylsulfinylbenzimidazoles - pharmacology | Enzyme Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - blood | Young Adult | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - pharmacology | Adult | Female | Omeprazole - pharmacology | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Enzyme Inhibitors - adverse effects | Proton Pump Inhibitors - adverse effects | Aryl Hydrocarbon Hydroxylases - antagonists & inhibitors | Double-Blind Method | Drug Administration Schedule | 2-Pyridinylmethylsulfinylbenzimidazoles - adverse effects | Omeprazole - administration & dosage | Enzyme Inhibitors - pharmacology | Omeprazole - adverse effects | Ticlopidine - analogs & derivatives | Cross-Over Studies | Prodrugs - adverse effects | Prodrugs - pharmacokinetics | Cytochrome P-450 CYP2C19 | Platelet Activation - drug effects | 2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage | Prodrugs - pharmacology | Ticlopidine - blood | Omeprazole | Pantoprazole | Drug interactions | Analysis | Dosage and administration | Research | Patients | Health aspects | Index Medicus | Abridged Index Medicus
Journal Article